Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe's growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Job Description
In this role, as the Biologics Business Development Lead you are responsible for building the Biologics partnering strategy by identifying areas and partners where our platform in collaborations with partners can address gaps in Biologics and related therapeutic modalities. You will be leading the expansion of Ginkgo's partnership in the Biologics space, both with biotechs and pharmaceutical companies, from conceptualization of partnership frameworks, to interfacing with internal technical teams to scope work, to negotiating and closing deals.
Want more jobs like this?
Get jobs that are Remote delivered to your inbox every week.
Responsibilities
- Accountable for Biologics deal targets to grow Ginkgo's partnerships with external companies
- Craft and pitch external narrative, value proposition, and technical offerings that attract customer interest
- Manage matrixed and direct reports to plan and execute on a singular, cohesive strategy to grow the Biologics product vertical
- Coordinate with enterprise account leads to cultivate new research collaboration deal opportunities with medium and large pharmaceutical companies
- Collaborate closely with the deal transaction team to lead agreement discussions, structure deals and lead deal negotiations with potential partners; in addition to leading deals, support and mentor BD team members with deal sourcing, deal structuring and negotiations.
- Grow Ginkgo's network within the biopharma ecosystem
- Participate in long-term planning and annual operating planning to set the strategy and tactics for Ginkgo's Biopharma commercial team
- Represent Ginkgo at industry events and shape the SynBio agenda across the industry
- Travel, as necessary, for conferences or partner meetings
- Minimum Bachelor's degree in engineering, and/or science; a PhD and Master degree in life science will be a plus.
- Typically 8-10+ YOE plus PhD (or equivalent experience with a Bachelor's), including proven experience growing and developing a team to deliver results.
- Demonstrated account management track record and experience in negotiating complex deals to build meaningful research collaboration partnerships
- Business development experience with attractive deal sheets (buy- or sell-side)
- Deep understanding of drug discovery and development across Biologics (tx antibodies, peptides, recombinant proteins)
- Ability to proactively identify problems for potential clients and offer solutions through Ginkgo's integrated service offerings
- Recognized business leader in biopharma pre-clinical research and development partnering
- Demonstrated networks to CSOs, Heads of Research, and Business Development at biotech and large pharma companies
- Prior experience within a fast-growth company or entrepreneurial environment is a plus.
- Excellent communication and presentation skills, with the ability to partner effectively with the executive team and cross-functional leaders throughout the company and communicate thoughtfully to diverse stakeholders
- Demonstrated commitment, self-motivation, and drive, and enthusiasm about being a part of Ginkgo's mission
To learn more about Ginkgo, visit www.ginkgobioworks.com/press/ or check out some curated press below:
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: 'If we try, we can win' (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
We're developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can - and will - impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it's something we'll be proud of as it continues to grow. Therefore, it's critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.
It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees, employment applicants, and EOE disability/vet.
Privacy Notice
I understand that I am applying for employment with Ginkgo Bioworks and am being asked to provide information in connection with my application. I further understand that Ginkgo gathers this information through a third-party service provider and that Ginkgo may also use other service providers to assist in the application process. Ginkgo may share my information with such third-party service providers in connection with my application and for the start of employment. Ginkgo will treat my information in accordance with Ginkgo's Privacy Policy. By submitting this job application, I am acknowledging that I have reviewed and agree to Ginkgo's Privacy Policy as well as the privacy policies of the third-party service providers used by Ginkgo's associated with the application process.